Clinical Trials Logo

Pain clinical trials

View clinical trials related to Pain.

Filter by:

NCT ID: NCT01032993 Active, not recruiting - Pain Clinical Trials

Clinical Trial of CoQ10 for Mild-to-Moderate Statin-Associated Muscle Symptoms

Start date: December 2009
Phase: Phase 2/Phase 3
Study type: Interventional

This study will evaluate whether a dietary supplement, coenzyme Q10 (CoQ10), will improve muscle symptoms, such as muscle aches, pains, cramps, and/or weakness, which are experienced by some individuals who use statin medications.

NCT ID: NCT00996983 Active, not recruiting - Pain Clinical Trials

Safety and Activity Study of Intrathecally Administered Ziconotide for Neuropathic Pain in Patients With Cancer

ZIDON
Start date: September 2009
Phase: Phase 2
Study type: Interventional

Neuropathic pain is difficult to control because it is only partially sensitive to opioid analgesics, and requires the addition of other therapies such as antidepressants and epileptics. Ziconotide is a drug that is used to treat neuropathic pain in patients who have had inadequate pain control with prior combination of medicines.

NCT ID: NCT00847028 Active, not recruiting - Pain Clinical Trials

Oral Glucose Solution as Pain Relief in Newborns: Results of a Clinical Trial

Start date: November 2007
Phase: N/A
Study type: Interventional

This study investigates which concentration of glucose is most effective in reducing pain for venipuncture in the newborn.

NCT ID: NCT00793052 Active, not recruiting - Pain Clinical Trials

Etodalac, Etoricoxib and Dexamethasone for Prevention of Pain ,Swelling and Trismus Following Third Molar Surgery

Start date: November 2008
Phase: N/A
Study type: Interventional

The purpose of this study is to determine whether Etodalac, Etoricoxib and Dexamethasone are effective for Prevention of Pain ,Swelling and Trismus Following Third Molar Surgery

NCT ID: NCT00785603 Active, not recruiting - Depression Clinical Trials

Paroxetines Effect on Tramadols Metabolism and Pharmakodynamics: a Dose Response Study

Start date: August 2008
Phase: Phase 4
Study type: Interventional

The purpose of the study is to examine the connection between the dose of paroxetine and the effect of paroxetine on tramadols metabolism and thereby the effect of tramadol on the median pupil size. In the study 12 healthy volunteers are going through 5 phases where they are suppose to consume a determined dose of tramadol and 5 various doses of paroxetine corresponding to the 5 phases. Fig 1. phases 1 2 3 4 5 Dosis Tramadol mg 50 50 50 50 50 Dosis Paroxetine mg Placebo 10 20 30 50 Paroxetin / placebo 2 ½ placebo 2 placebo 1 ½ placebo 1 placebo tablets ½ paroxetine 1 paroxetine 1 ½ paroxetine 2 ½ paroxetine Fig. 1 summary of the 5 phases There is a variation in the time where maximal plasma concentration is obtained in consumption of respectively tramadol (1 - 2 hours) and paroxetine (6 hours). For that reason there has to be at least 6 hours between the administration of paroxetine and tramadol. The healthy volunteer brings the research medicine home and consumes it before bedtime the night before the day of the study. At eight o'clock next morning the healthy volunteer arrives to the first pupil measurement and consumption of tramadol. Tree hours later the next pupil measurement is carried through. The healthy volunteer accumulates his or her urine until 2 pm. As paroxetine is a irreversible inhibitor of the enzyme CYP2D6 there has to go at least 14 days before the next phase takes place. In that amount of time there can be recreated a new pool of enzyme.

NCT ID: NCT00708019 Active, not recruiting - Pain Clinical Trials

Improving Cancer Pain Management Through Self-Care

Start date: December 2007
Phase: N/A
Study type: Interventional

This study will test two different doses of a psychoeducational intervention to improve cancer pain management. In addition, the study will determine if the changes in pain management behaviors that the patients and family caregivers learn continue to be used when the intervention stops. It is hypothesized that patients and family caregivers who receive the high dose intervention will have a greater decrease in pain intensity scores.

NCT ID: NCT00675779 Active, not recruiting - Pain Clinical Trials

Efficacy Study of Atorvastatin in Pelvic Pain Relief in Women With Endometriosis

EndoStatin
Start date: April 2008
Phase: N/A
Study type: Interventional

The purpose of this study is to determine whether atorvastatin (alone or in combination with oral contraceptive) is effective in treatment of pelvic pain and inflammatory response in women with endometriosis.

NCT ID: NCT00349024 Active, not recruiting - Pain Clinical Trials

Polyvinylpyrrolidone-Sodium Hyaluronate Gel in Reducing Pain From Oral Mucositis in Young Patients With Cancer

Start date: July 2005
Phase: N/A
Study type: Interventional

RATIONALE: Polyvinylpyrrolidone-sodium hyaluronate gel may lessen the pain of oral mucositis, or mouth sores, in patients undergoing treatment for cancer. PURPOSE: This clinical trial is studying how well polyvinylpyrrolidone-sodium hyaluronate gel works in reducing pain from oral mucositis in young patients with cancer.

NCT ID: NCT00313573 Active, not recruiting - Depression Clinical Trials

Telemedicine or Standard Care in Treating Patients With Depression and/or Pain Caused By Cancer

Start date: February 2006
Phase: Phase 3
Study type: Interventional

RATIONALE: Telemedicine may help in the treatment of depression and/or pain caused by cancer. It is not yet known whether telemedicine is more effective than standard care in treating depression and/or pain caused by cancer. PURPOSE: This phase III randomized clinical trial is studying telemedicine to see how well it works compared to standard care in treating patients with depression and/or pain caused by cancer.

NCT ID: NCT00237523 Active, not recruiting - Pain Clinical Trials

Study for Treatment of Moderate or Severe, Periodic, "Cyclic", Breast Pain

Start date: July 2005
Phase: Phase 3
Study type: Interventional

- History of clinical breast pain for at least the last six months. - At least six days of moderate or severe breast pain per cycle. - Fibrosis, cysts, nodules involving at least 25% of the surface of one breast. - Euthyroid with no prior history of thyroid disease. - Six months of daily therapy with molecular iodine. - Placebo controlled vs active (1:1).